1 - 25 of 3
Number of results to display per page
TitleCreatorRelation Is Part Of
1 Orally Administered SIRTl Activator SRT501 is Neuroprotective for Retinal Ganglion Cells and Suppresses Neurological Dysfunction in a Mouse Model of Multiple SclerosisKenneth S. Shindler; Elvira Ventura; Peter Elliott; A.M. RostamiNANOS 2008: Platform Session I
2 Retinal Ganglion Cell Loss in a Mouse Model of Optic NeuritisFrancois Evoy, MD; Julie Prévost; Marie-Ève Arsenault
3 Sirtuin-Activating Compounds Prevent Retinal Ganglion Cell Loss During Acute Optic NeuritisKenneth S. Shindler; Abdolmohamad M. RostamiNANOS 2006: Scientific Platform Presentations (Session I)
1 - 25 of 3